This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The study is expected to be the world’s first Phase 2a clinicaltrial evaluating the efficacy of psilocybin and psychotherapy to treat fibromyalgia. The open-label Phase 2a clinicaltrial will evaluate the efficacy of TRYP-8802, an oral formulation of synthetic psilocybin, in tandem with psychotherapy for treating fibromyalgia.
CBN has made headlines and claimed shelf space as the next best cannabinoid for sleep. MoreBetter, creators of the Releaf App, is using this real world data to push back against the claim that there’s no evidence that CBN can help people sleep. It also, allegedly, helps with sleep (more on that below). Back to our study.
Many patients are turning to cannabis for insomnia relief, seeking its potential to improve sleep quality and duration. Insomnia is a common sleep disorder characterized by difficulty falling asleep, staying asleep, or experiencing non-restorative sleep despite having the opportunity to sleep.
IGC”) (NYSE American: IGC) announces today that it has completed Cohort 2 of its Phase 1 clinicaltrial on IGC’s tetrahydrocannabinol (“THC”)-based investigational new drug, IGC-AD1, intended to alleviate the symptoms of individuals suffering from Alzheimer’s disease. This Phase 1 trial is currently testing IGC-AD1 for safety.
And it does appear to address some of the main issues that people turn to cannabis for — inflammation, pain, anxiety, sleep problems, depression, and cancer. It was highly rated for anxiety, pain, depression, and sleep problems. But we may be on the cusp of having those trials, which would be very exciting.
Of course, this plant is now known to be marijuana (or Type I cannabis), which is still commonly used for sleep and analgesia today. CBN has been receiving a lot of attention for its ability to induce sleep, as it’s frequently marketed as nature’s sleep aid. What can the current clinicaltrials tell us?
Taken together, the lack of guidance and lack of information about what treatments patients are taking, may underlie “inconsistencies in both use and reported effectiveness,” the researchers stated. Where do Parkinson’s patients get information about cannabis? Here are the most interesting statistics from the survey. Of the 43.9%
Post-Traumatic Stress Disorder (PTSD) is a multifaceted mental health condition triggered by experiencing or witnessing traumatic events, persistently manifesting in symptoms like flashbacks, severe anxiety, and disrupted sleep. Need more information about medical marijuana as a treatment? Check it out today for additional information!
Sleep Improvement: Many PTSD sufferers experience insomnia and nightmares. Cannabis, particularly strains high in THC, can improve sleep quality and reduce the frequency of nightmares. Various clinicaltrials are investigating the effectiveness of cannabis and its components in treating PTSD symptoms.
. * The most common non-motor symptoms that cannabis users were trying to treat with their cannabis use were anxiety, pain, and sleep disorders. Of those who were provided information, the most common sources were non-Parkinson’s disease doctors, dispensary staff, and other individuals with Parkinson’s.
My partner, who was diagnosed with Crohn’s Disease at the age of 19, was able to improve his quality of life with cannabis by managing his nausea, poor quality sleep, gut motility, appetite, pain, and anxiety with a single substance. The more I read about it, the more I became fascinated with the chemistry and potential of cannabis.
The Company and Its Subsidiary KGK Science Have Also Completed the Pre-Qualification Audits of Its Canadian Facilities to Enable ClinicalTrials in an Arrangement with Aleafia Health. The audits will enable KGK to conduct clinicaltrials in the areas of psychedelics and nutraceuticals, among other substances of study.
Others say if they use before bedtime, they can’t sleep, they stay awake all night. Dr. Weil: Yes, first of all, there’s been a big demand for information about cannabis from our Fellows, the people in our programs, they want to learn about it. Weil: Yes, I think there needs to be more information.
The outcomes and measures used throughout the trial included changes in CUD symptoms; anxiety and depressive symptoms; pain severity; and insomnia symptoms. ClinicalTrial Sample Size. Missing Information. While lengthy, there is a surprising amount of missing information in the study.
With clinical research developing rapidly in Israel and with the use of innovative technology we hope to have this information in the near future. Of 272 combined patients, 86% experienced some clinical benefit, and 10% experienced a complete clinical response. improvement in good sleep. References Staff, T.
The athletes who co-used THC and CBD reported the most benefits from cannabis, including reductions in pain and anxiety and improved sleep; this group also reported the highest level of adverse experiences (at a much lower rate than positive benefits) of increased appetite and diminished concentration. About Canna Research Group.
The athletes who co-used THC and CBD reported the most benefits from cannabis, including reductions in pain and anxiety and improved sleep; this group also reported the highest level of adverse experiences (at a much lower rate than positive benefits) of increased appetite and diminished concentration. About Canna Research Group.
It’s important to stay informed about current laws because they affect everything from what products are available to how they can be used. It’s used for everything from stress relief to sleep support, and it’s available in many places without needing a prescription. CBD , on the other hand, is generally more accessible.
As a devastating diagnosis, patients with a terminal illness must not only learn to cope with this information about their health but find restorative ways to alleviate the most common symptoms and effects. This is largely due to the way THC interacts and binds with endocannabinoids in our ECS.
A four-week clinicaltrial found that Spravato, when combined with an oral antidepressant, led to greater reductions in depression symptoms compared to a placebo with an oral antidepressant. Euphoria : Including intoxication and impairment; users should not drive nor operate heavy machinery until the next day after restful sleep.
Read our post Understanding the Endocannabinoid System: A Guide for Medical Marijuana Patients for more detailed information. In this section, we explore how medical marijuana can alleviate spasticity, pain, and stiffness, enhance sleep and mood, and offer various consumption methods to cater to individual preferences and medical needs.
(OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinicaltrial on neuropathic and post-operative pain. Logo – [link]. SOURCE SciSparc Ltd.
During the four-week study, participants will use the Radicle Science platform to track consumption and effectiveness of orally ingested CBD products on well-being, quality of life, pain, sleep disturbance, and anxiety.
A full night’s sleep is integral to overall health and wellbeing. Seven to nine hours of uninterrupted sleep is recommended each night. The optimum amount of sleep not only ensures rest but also enough energy for the next day. According to studies, as many as 70% of Americans report not being able to sleep the recommended hours.
Anxiety and sleep disorders were some reasons given for prescriptions despite lack of evidence for cannabis treatment, researchers find. of prescriptions were for sleep disorders. We are aware of clinicaltrials in that space, but not strong evidence.”. The Guardian writes. Read their full article at.
cbdMD began its first phase of research in the Fall of 2020, with its first in vivo animal study and clinicaltrials. Our cbdMD brand currently includes over 130 SKUs of high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD bath bombs, CBD bath salts, CBD sleep aids and CBD drink mixes.
DENVER–(BUSINESS WIRE)– Ripple , Colorado’s trusted cannabis edibles brand and pioneer of fast-acting and clinically proven technology, is leading the way in cannabis wellness with new Ripple Sleep QuickDissolves and Ripple Sleep QuickGummies. faster), and Ripple Dissolvables (1.9X
Clinicaltrials and studies are underway to examine the potential benefits and risks of MMJ as a treatment option for epilepsy. These studies aim to provide evidence-based guidance for patients, healthcare providers, and policymakers, paving the way for more informed decisions regarding the use of MMJ in epilepsy management.
VA health care providers will record marijuana use in the veteran’s VA medical record in order to have the information available in treatment planning. As with all clinicalinformation, this is part of the confidential medical record and protected under patient privacy and confidentiality laws and regulations.
What most people don’t understand is that CBD may be helpful for symptom management for conditions such as anxiety, inflammation, pain, sleep and certain types of seizures, however, figuring out how to achieve those effects is a bit more complicated. So, those labels on CBD bottles in the store with dosing information may not help you at all.
The double-blind, randomised, placebo-controlled clinicaltrial took place over two years between 2017 and 2019 at the Center for Medicinal Cannabis Research at the University of California. As many patients use cannabis-based medicines to aid with sleep, the current detection window is of significant concern.
The endocannabinoid system has been shown to help regulate many key functions such as sleep, hunger, mood, immune response, and memory. In a regulatory framework without standards or oversight, none of this matters — you have no way of knowing whether the label information is accurate. Delta-8-THC research.
This information can help you and your healthcare provider adjust your treatment plan as needed. CBD may also help alleviate anxiety and improve sleep, which can be beneficial for patients with chronic pain. Monitor Your Progress: Keep a journal to track your symptoms, dosage, and response to treatment.
In fact, from pediatricians to geriatricians, I cannot think of any medical practitioner that does not need to be well informed about the endocannabinoid system and cannabis-based therapeutics. It is a provider that the patient sees once or maybe twice, and there’s no mandatory follow up with the recommending clinician.
It controls things like mood, stress, and even sleep. Clinicaltrials have been looking into both THC and CBD and their individual roles in treating anxiety. Linalool, which smells like lavender, is often used to promote relaxation and sleep. Knowing the risks can help you make an informed decision about your treatment.
While discussing cannabinoid therapy with my patients, I often share that we’re not just treating chorea or sleep disturbances we’re preserving moments. The research numbers are promising yes, we see significant improvements in sleep quality and motor function.
Clinicaltrials across the EU have also shown CBD oils and other hemp products to have a potential range of benefits. When you use these substances, they can impact things like memory, sleep, mood, and pain. Also, alone it won’t create the “high” sensation associated with the use of Tetrahydrocannabinol or THC. Final Note.
Cannabinoids (natural and plant-derived) interact with endocannabinoid receptors to regulate appetite, sleep, pain, stress, and more. For more information, see: What Is Hemp & Why Does It Matter? ). Prior to receiving FDA approval, Epidiolex underwent a number of clinicaltrials establishing the medical efficacy of CBD.
But despite the growing popularity of CBD items, various myths surround this product that make it difficult for some individuals to make an informed decision. It interacts with different receptors to regulate stress, sleep schedule, pain management, immune system, mood, etc. So, it doesn’t cause high feelings. Myth # 2: CBD is Illegal.
Those insights will help bring products to market that are specifically formulated based on rigorous evidence to address need states like chronic pain, restful sleep, and general health and well-being. For more information, visit [link] and follow their LinkedIn page. About Radicle Science.
By understanding the mechanisms and nuances of cannabis use, individuals can make informed decisions about integrating it into their treatment regimen. Clinical Research Findings: What Studies Say About Cannabis and Anxiety Numerous studies have explored cannabis’s efficacy in alleviating anxiety symptoms.
After several trials with traditional forms of therapy and medication with no long-term effectiveness, researchers decided to give CBD oil a shot. To their surprise, the patient was able to have long-term, sustained results of lower levels anxiety as well as better and longer sleep. A New Kind of Treatment.
For instance, Marijuana oil is used for the treatment of cancer and nausea and can also be used for the improvement of the sleep cycle and alleviating stress, pain, and anxiety. Global Legal Cannabis Industry: Number of ClinicalTrials, By Region. For more information about this report visit [link]. Market Segmentation.
The four-week Institutional Review Board (IRB) approved randomized controlled trial (RCT) of nearly 3,000 participants assigned to different botanical products containing CBD revealed significant improvement across all five health outcomes studied: well-being, quality of life, longer-term pain, feelings of anxiety, and sleep quality.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content